{{header
 | author     = Keith Ellison
 | related_author = United States Congress
 | translator = 
 | section    = 
 | previous   = 
 | next       = 
 | year       = 2013
 | month      = 12
 | day        = 12
 | notes      = ''{{USBill|113|H.R.|3715}}'' as introduced
 | categories =
 | portal     =
 | congress   = 113
 | session    = 1
 | title      = Personal Drug Importation Fairness Act of 2013 ( H.R. 3715; 113th Congress)
 | bill       = 3715
 | billtype   = hr
 | purpose    = To reduce prescription drug costs by allowing the importation and reimportation of certain drugs.
 | wikipedia  =
}}

{{Center|113th CONGRESS}}


{{Center|1st Session}}


{{Center|H. R. 3715}}


{{Center|IN THE HOUSE OF REPRESENTATIVES}}


{{Center|December 12, 2013}}


{{Center|
shitburger[[w:Keith Ellison|Mr. Ellison]] (for himself and
shitburger[[w:Dana Rohrabacher|Mr. Rohrabacher]] ) introduced the following bill; which was referred to the [[w:United States House Committee on Energy and Commerce|Committee on Energy and Commerce]] }}


{{Center|A BILL}}

To reduce prescription drug costs by allowing the importation and reimportation of certain drugs.

=Section 1. Short title=

This Act may be cited as the “Personal Drug Importation Fairness Act of 2013” .

=Sec. 2. Reducing prescription drug costs by allowing certain drugs to be imported or reimported=



==(a) In general– ==

Notwithstanding any provision of the Federal Food, Drug, and Cosmetic Act( [http://www.law.cornell.edu/uscode/text/21/301 21 U.S.C. 301 et seq] .), a drug may be imported into the United States, and may be reimported into the United States by a person other than the drug’s manufacturer, if the drug—
:(1) has the same active ingredients, route of administration, and strength as a prescription drug approved under chapter V of such Act( [http://www.law.cornell.edu/uscode/text/21/351 21 U.S.C. 351 et seq] .);
:(2) may be lawfully marketed in, and is imported or reimported from, a qualified country;
:(3) is dispensed by a licensed pharmacist;
:(4) is shipped directly to, or is imported by, the ultimate consumer from the qualified country;
:(5) is shipped or imported in quantities that do not exceed a 90-day supply; and
:(6) is accompanied by a copy of a valid prescription.

==(b) Definitions– ==

In this Act:
:(1) The term drug has the meaning given to such term in section 201 of the Federal Food, Drug, and Cosmetic Act( [http://www.law.cornell.edu/uscode/text/21/321 21 U.S.C. 321] ), except that such term excludes any controlled substance (as defined in section 102 of the Controlled Substances Act( [http://www.law.cornell.edu/uscode/text/21/802 21 U.S.C. 802] )).
:(2) The term prescription drug means a drug subject to section 503(b)(1) of the Federal Food, Drug, and Cosmetic Act( [http://www.law.cornell.edu/uscode/text/21/353 21 U.S.C. 353(b)(1)] ).
:(3) The term qualified country means a country that—
::(A) is Australia, Canada, Israel, Japan, New Zealand, Switzerland, South Africa, a member-state of the European Union, or a country in the European Economic Area; and
::(B) is determined by the [[w:Food and Drug Administration|Commissioner of Food and Drugs]] to have standards for ensuring the safety and effectiveness of drugs that are at least as protective as such standards in the United States.
{{PD-USGov}}
[[Category:Proposed United States federal law]]
[[Category:Proposed United States federal law of the 113th Congress]]
